“We only take returns of medicine directly supplied from us”

While pharmaceutical distribution companies are seeking for solutions for the 1.5 year suspension as an administrative measure from violating the serial number system, some pharmaceutical companies were criticized for taking advantages of the system for their own benefits to block return of medicines.

According to the industry concerned, pharmaceutical companies have informed distribution comp...